Malcolm Richardson
#39,457
Most Influential Person Now
Medical mycologist
Malcolm Richardson's AcademicInfluence.com Rankings
Malcolm Richardsonbiology Degrees
Biology
#9545
World Rank
#12762
Historical Rank
Pathology
#172
World Rank
#300
Historical Rank
Microbiology
#668
World Rank
#737
Historical Rank
Download Badge
Biology
Malcolm Richardson's Degrees
- PhD Medical Mycology University of Manchester
- Masters Medical Mycology University of Manchester
- Bachelors Microbiology University of Manchester
Why Is Malcolm Richardson Influential?
(Suggest an Edit or Addition)According to Wikipedia, Malcolm D. Richardson is Director of the Mycology Reference Centre, Manchester University NHS Foundation Trust at Wythenshawe Hospital and an honorary Professor of Medical Mycology at the University of Manchester.
Malcolm Richardson's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. (2012) (1017)
- Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. (2018) (801)
- Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. (2019) (720)
- ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. (2014) (710)
- EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts: Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST)∗ (2008) (579)
- Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. (2011) (573)
- Changing patterns and trends in systemic fungal infections. (2005) (521)
- Changing epidemiology of systemic fungal infections. (2008) (488)
- Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology. (2014) (485)
- ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. (2014) (387)
- ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. (2012) (343)
- Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009. (2010) (282)
- ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). (2012) (280)
- ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. (2012) (267)
- β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3). (2012) (258)
- ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. (2014) (251)
- Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris (2017) (250)
- The ecology of the Zygomycetes and its impact on environmental exposure. (2009) (224)
- Fungal Infection: Diagnosis and Management (1993) (222)
- Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts (2003) (195)
- Novel immunologic classification of aspergillosis in adult cystic fibrosis. (2013) (194)
- Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing. EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. (2009) (158)
- Candida yeasts in chronic periodontitis tissues and subgingival microbial biofilms in vivo. (2004) (142)
- Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST). (2003) (134)
- Emergence of Fluconazole Resistance in a Candida parapsilosis Strain That Caused Infections in a Neonatal Intensive Care Unit (2005) (133)
- The European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST) EUCAST Technical Note on fluconazole. (2009) (130)
- Detection and investigation of invasive mould disease. (2011) (128)
- ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases. (2012) (123)
- Sampling of Aspergillus spores in air. (2000) (115)
- Comparison of six Aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis (CPA). (2016) (111)
- Transcriptome Assembly and Profiling of Candida auris Reveals Novel Insights into Biofilm-Mediated Resistance (2018) (111)
- Aspergillus felis sp. nov., an Emerging Agent of Invasive Aspergillosis in Humans, Cats, and Dogs (2013) (109)
- Histoplasmosis in Africa: An emerging or a neglected disease? (2018) (107)
- Aspergillosis in immunocompromised paediatric patients: associations with building hygiene, design, and indoor air. (1996) (107)
- Results of surgery for chronic pulmonary Aspergillosis, optimal antifungal therapy and proposed high risk factors for recurrence - a National Centre’s experience (2013) (101)
- Opportunistic and pathogenic fungi. (1991) (96)
- In-vitro resistance to imidazole antifungals in Candida albicans. (1984) (95)
- Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation (1997) (94)
- ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS. (2012) (89)
- A systematic review of fluconazole resistance in clinical isolates of Cryptococcus species (2018) (88)
- Influence of food on the pharmacokinetics of ketoconazole (1984) (88)
- Chronic pulmonary aspergillosis commonly complicates treated pulmonary tuberculosis with residual cavitation (2019) (87)
- Computer-assisted rapid enzyme-linked immunosorbent assay (ELISA) in the serological diagnosis of aspergillosis. (1983) (85)
- Performance of two Aspergillus IgG EIA assays compared with the precipitin test in chronic and allergic aspergillosis. (2013) (84)
- EUCAST technical note on fluconazole. (2008) (84)
- Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology. (2021) (79)
- Antibody testing in aspergillosis--quo vadis? (2015) (79)
- Clinical manifestations and management of aspergillosis in the compromised patient. (1990) (77)
- Emerging issues, challenges, and changing epidemiology of fungal disease outbreaks. (2017) (75)
- In Vitro Susceptibility of Aspergillus fumigatus to Isavuconazole: Correlation with Itraconazole, Voriconazole, and Posaconazole (2013) (73)
- Fortnightly Review: Fungal nail disease: a guide to good practice (report of a Working Group of the British Society for Medical Mycology) (1995) (71)
- Volume dependency for culture of fungi from respiratory secretions and increased sensitivity of Aspergillus quantitative PCR (2014) (71)
- Case Definition of Chronic Pulmonary Aspergillosis in Resource-Constrained Settings (2018) (71)
- Prevention and monitoring of invasive fungal infections in pediatric patients with cancer and hematologic disorders (2007) (70)
- Resistance of virulent and attenuated strains of Candida albicans to intracellular killing by human and mouse phagocytes. (1981) (70)
- Diagnosis of invasive candidosis by enzyme immunoassay of serum antigen. (1977) (67)
- Immunodiagnosis of invasive fungal infection. (1992) (66)
- Treatment of pulmonary aspergilloma with itraconazole. (1991) (66)
- Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients. (2010) (63)
- Delivering on Antimicrobial Resistance Agenda Not Possible without Improving Fungal Diagnostic Capabilities (2017) (63)
- Non-Candida albicans Candida yeasts of the oral cavity (2007) (62)
- Fungal colonization of haematological patients receiving cytotoxic chemotherapy: emergence of azole-resistant Saccharomyces cerevisiae. (2000) (61)
- Fungal infection in the compromised patient. (1982) (61)
- A Review of Onychomycosis Due to Aspergillus Species (2017) (60)
- Optimum conditions for initiation of filamentation in Candida albicans. (1975) (60)
- Diagnosis and treatment of invasive fungal infections: looking ahead (2019) (58)
- MODIFIED RESPONSE TO KETOCONAZOLE OF CANDIDA ALBICANS FROM A TREATMENT FAILURE (1983) (57)
- Chronic pulmonary aspergillosis as a cause of smear-negative TB and/or TB treatment failure in Nigerians. (2017) (56)
- Germination of Trichophyton mentagrophytes on human stratum corneum in vitro. (1992) (55)
- Adherence of arthroconidia and germlings of anthropophilic and zoophilic varieties of Trichophyton mentagrophytes to human corneocytes as an early event in the pathogenesis of dermatophytosis (1993) (55)
- Decreased susceptibility of Candida albicans to azole antifungals: a complication of long-term treatment in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients. (2007) (54)
- ANTIFUNGAL THERAPY IN ‘BONE MARROW FAILURE’ (1998) (53)
- Role of Serological Tests in the Diagnosis of Mold Infections (2018) (53)
- Relevance of Antigenicity of Candida Albicans Growth Phases to Diagnosis of Systemic Candidiasis (1973) (53)
- Enhanced phagocytosis and intracellular killing of Candida albicans by GM-CSF-activated human neutrophils. (1992) (53)
- Azole Antifungal Resistance Today: Focus on Aspergillus (2011) (51)
- How the host fights against Candida infections. (2009) (50)
- Multiple dose pharmacokinetics of ketoconazole and their effects on antipyrine kinetics in man. (1983) (49)
- New perspectives in the diagnosis of systemic fungal infections. (1999) (49)
- The human lung and Aspergillus: You are what you breathe in? (2019) (46)
- Production of germ tubes by virulent and attenuated strains of Candida albicans. (1981) (45)
- The effect of growth medium of filament production in Candida albicans. (1974) (43)
- Epidemiologic study by DNA typing of a Candida albicans outbreak in heroin addicts (1991) (43)
- High-volume culture and quantitative real-rime PCR for the detection of Aspergillus in sputum. (2019) (42)
- Reduction of fluconazole susceptibility of Candida albicans in APECED patients due to long-term use of ketoconazole and miconazole (2008) (41)
- Aspergillus serology: Have we arrived yet? (2017) (41)
- Intracellular localization of Porphyromonas gingivalis thiol proteinase in periodontal tissues of chronic periodontitis patients. (2004) (40)
- Cryptococcus neoformans var. grubii isolates recovered from persons with AIDS demonstrate a wide range of virulence during murine meningoencephalitis that correlates with the expression of certain virulence factors. (2006) (39)
- Rapid enzyme-linked immunosorbent assay (ELISA) for Aspergillus fumigatus antibodies. (1982) (39)
- Erratum: The European Committee on antimicrobial susceptibility testing - Subcommittee on antifungal susceptibility testing (EUCAST-AFST)*. EUCAST technical note on fluconazole (Clinical Microbiology and Infection (2008) vol. 14(2) (193-195)) (2009) (39)
- Source of infection in candida endophthalmitis in drug addicts. (1986) (37)
- Systemic fungal infections (2017) (37)
- Optimal sampling site for mucosal candidosis in oral cancer patients is the labial sulcus. (2006) (36)
- Fermentative 2-carbon metabolism produces carcinogenic levels of acetaldehyde in Candida albicans. (2013) (36)
- Diagnosis and prevention of fungal infection in the immunocompromized patient. (1998) (36)
- IgA and IgG antibodies to Candida albicans in the genital tract secretions of women with or without vaginal candidosis. (1984) (35)
- Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candidiasis. (2008) (34)
- Candida albicans does not invade carious human dentine. (2007) (33)
- Enzyme-linked immunosorbent assay and its application to the serological diagnosis of fungal infection. (1983) (32)
- A comparative study of the efficacy of fluconazole and amphotericin B in the treatment of oropharyngeal candidosis in patients undergoing radiotherapy for head and neck tumours. (1996) (32)
- Effect of imidazole antifungals on the development of germ tubes by strains of Candida albicans. (1983) (31)
- Reactive oxygen: A novel antimicrobial mechanism for targeting biofilm-associated infection. (2017) (31)
- In-vitro effect of itraconazole, ketoconazole and amphotericin B on the phagocytic and candidacidal function of human neutrophils. (1986) (30)
- Receiver operating characteristic curve analysis of four Aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis. (2018) (30)
- Evaluation of LDBio Aspergillus ICT Lateral Flow Assay for IgG and IgM Antibody Detection in Chronic Pulmonary Aspergillosis (2019) (29)
- Fungal surveillance of an open haematology ward. (2000) (28)
- Exposure to Aspergillus in Home and Healthcare Facilities’ Water Environments: Focus on Biofilms (2019) (28)
- Essential in vitro diagnostics for advanced HIV and serious fungal diseases: international experts’ consensus recommendations (2019) (27)
- Pathogenesis of superficial mycoses. (1994) (25)
- The role of occupational Aspergillus exposure in the development of diseases. (2019) (25)
- Biotic Environments Supporting the Persistence of Clinically Relevant Mucormycetes (2019) (25)
- Opsonic effect of C-reactive protein on phagocytosis and intracellular killing of virulent and attenuated strains of Candida albicans by human neutrophils. (1991) (24)
- Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation (2018) (24)
- Comparative performance of Aspergillus galactomannan ELISA and PCR in sputum from patients with ABPA and CPA. (2017) (23)
- Cryptococcal Antigenemia in Nigerian Patients With Advanced Human Immunodeficiency Virus: Influence of Antiretroviral Therapy Adherence (2016) (23)
- Siemens Immulite Aspergillus-specific IgG assay for chronic pulmonary aspergillosis diagnosis (2019) (22)
- Clinical manifestations and management of candidosis in the compromised patient. (1990) (22)
- Stimulation of neutrophil phagocytosis of Aspergillus fumigatus conidia by interleukin-8 and N-formylmethionyl-leucylphenylalanine. (1995) (22)
- Effect of Lamisil and azole antifungals in experimental nail infection. (1997) (20)
- Invasive aspergillosis due to Aspergillus section Usti: a multicenter retrospective study. (2020) (20)
- Epidemiology of an outbreak of Candida endophthalmitis in heroin addicts: identification of possible source of infection by biotyping. (1988) (19)
- Development and validation of the European QUALity (EQUAL) score for mucormycosis management in haematology. (2019) (19)
- Candidosis of the genital tract in non-pregnant women. (1985) (18)
- Frequency of Pneumocystis jirovecii in sputum from HIV and TB patients in Namibia. (2014) (18)
- Introduction to the management of fungal infection in the compromised patient. (1990) (18)
- Evaluation of the Oricult-N Dipslide for Laboratory Diagnosis of Vaginal Candidiasis (2000) (18)
- Activity of terbinafine on Trichophyton mentagrophytes in a human living skin equivalent model. (1995) (17)
- Clinical manifestations and management of mucormycosis in the compromised patient. (1990) (17)
- Examination on Candida spp. in refractory periapical granulomas. (2003) (17)
- The Provox™ voice prosthesis and Candida albicans growth: a preliminary report of clinical, mycological and scanning electron microscopic assessment (1994) (16)
- Diagnosis and Management of Pneumocystis Pneumonia in Resource-poor Settings (2018) (16)
- Clinical manifestations and management of cryptococcosis in the compromised patient. (1990) (16)
- Differentiation of extracellular from ingested Candida albicans blastospores in phagocytosis tests by staining with fluorescein-labelled concanavalin A. (1982) (15)
- Expression of interleukin-8 and its receptor IL-8RA in chronic hyperplastic candidosis. (2006) (15)
- Negative impact of Aspergillus galactomannan and DNA detection in the diagnosis of fungal rhinosinusitis. (2007) (15)
- Clinical manifestations and management of hyalohyphomycosis, phaeohyphomycosis and other uncommon forms of fungal infection in the compromised patient. (1990) (15)
- Evaluation of the LDBio Aspergillus ICT lateral flow assay for serodiagnosis of allergic bronchopulmonary aspergillosis (2020) (15)
- Diagnosis and pathogenesis of dermatophyte infections. (1990) (15)
- Fungal infection in the compromised patient. 2nd edition. (1991) (15)
- Possible role of preserved lemon juice in the epidemiology of candida endophtalmitis in heroin addicts (2005) (15)
- Air sampling for aspergillus spp. during building activity in a paediatric hospital ward. (1995) (14)
- Prior subclinical histoplasmosis revealed in Nigeria using histoplasmin skin testing (2018) (14)
- Aspergillus flavus endocarditis in a child with neuroblastoma. (1998) (14)
- Evaluation of a rapid enzyme-linked immunosorbent assay for IgG antibodies to Aspergillus fumigatus in the serological diagnosis of allergic aspergillosis. (1984) (14)
- Isavuconazole Therapeutic Drug Monitoring during Long-Term Treatment for Chronic Pulmonary Aspergillosis (2020) (13)
- Microbiology of chronic hyperplastic sinusitis. (2004) (13)
- Inhibitory effect of terbinafine on the invasion of nails by Trichophyton mentagrophytes. (1995) (13)
- An in vitro model of dermatophyte invasion of the human hair follicle. (1996) (12)
- High performance liquid chromatographic (HPLC) and other non-biological methods for quantitation of antifungal drugs. (1982) (12)
- Mycology Laboratory Diagnostic Capacity for Invasive Fungal Diseases in 2017: Results of a National Survey. (2019) (12)
- Fungal infections: a survey of laboratory services for diagnosis and treatment. (1996) (12)
- Intracellular localization of Treponema denticola chymotrypsin-like proteinase in chronic periodontitis (2014) (12)
- Specificity of the monoclonal antibody 3H8 in the immunohistochemical identification of Candida species. (2006) (12)
- A novel method for sampling the microbiota from the oral mucosa (2009) (12)
- Acute Aspergillus pneumonia associated with mouldy tree bark-chippings, complicated by anti-glomerular basement membrane disease causing permanent renal failure☆ (2013) (12)
- Model Systems for the Study of Dermatophyte and Non-Dermatophyte Invasion of Human Keratin (2000) (11)
- Diagnostic Aspects of Chronic Pulmonary Aspergillosis: Present and New Directions (2019) (11)
- Effect of cilofungin on phagocytosis and intracellular killing ofCandida albicans by human neutrophils (2005) (11)
- Multicenter evaluation of Microring YT, a new method of yeast identification (1990) (11)
- Therapeutic drug monitoring and adverse events of delayed-release posaconazole tablets in patients with chronic pulmonary aspergillosis (2018) (10)
- Fungal Infection in the Compromised Host (1992) (10)
- Differential Proinflammatory Responses to Aspergillus fumigatus by Airway Epithelial Cells In Vitro Are Protease Dependent (2021) (10)
- The antiseptic Miramistin: a review of its comparative in vitro and clinical activity. (2020) (10)
- Clinical manifestations and management of histoplasmosis in the compromised patient. (1990) (10)
- Antigen and antibody attachment in ELISA for Aspergillus fumigatus IgG antibodies. (1984) (10)
- Circulating antigen of Aspergillus fumigatus in cortisone-treated mice challenged with conidia: Detection by counterimmunoelectrophoresis (1977) (10)
- Differential binding of acapsulate and encapsulated strains of Cryptococcus neoformans to human neutrophils. (1993) (9)
- The occurrence and treatment of false positive reactions in enzyme-linked immunosorbent assays (ELISA) for the presence of fungal antigens in clinical samples. (1979) (9)
- Pulmonary Aspergillosis in Patients with Suspected Ventilator-associated Pneumonia in UK Intensive Care Units. (2020) (9)
- First isolation of the pan-azole-resistant Aspergillus fumigatus cyp51A TR46/Y121F/T289A mutant in a UK patient. (2017) (9)
- High-volume Sputum Culture for the Diagnosis of Pulmonary Aspergillosis (2017) (8)
- A case of pulmonary cryptococcoma due to Cryptococcus gattii in the United Kingdom (2018) (8)
- Colonization of living skin equivalents by Malassezia furfur. (1998) (8)
- Rapid serological diagnosis of Aspergillus fumigatus infection of the frontal sinuses and nasal chambers of the dog. (1982) (8)
- Trichosporon japonicum Fungemia and Ventricular Assist Device Infection in an Immunocompetent Patient (2019) (8)
- ADH1 expression inversely correlates with CDR1 and CDR2 in Candida albicans from chronic oral candidosis in APECED (APS-I) patients. (2011) (8)
- Interaction of Candida krusei with human neutrophils in vitro. (1994) (8)
- In vitro susceptibility of Trichophyton mentagrophytes arthroconidia to clotrimazole and griseofulvin in human corneocyte suspensions (1991) (7)
- An introduction to antifungal stewardship. (2016) (7)
- Dormancy of Trichophyton mentagrophytes arthroconidia. (1992) (7)
- Lipid complexes of amphotericin B: the competitive picture. (1997) (7)
- Measurement of serum arabinitol by gas-liquid chromatography: limitations for detection of systemic candida infections. (1993) (7)
- Relevance ofAntigenicity ofCandida Albicans GrowthPhases toDiagnosis ofSystemic Candidiasis (1973) (7)
- Pathogenesis of dermatophytosis. (1993) (7)
- Sequence analysis of isolates of Aspergillus from patients with chronic and allergic aspergillosis reveals a spectrum of cryptic species. (2018) (7)
- Executive Summary of the 2017 ESCMID -ECMM Guideline for the Diagnosis and Management of Aspergillus Disease (2018) (7)
- Effect of patient immunodeficiencies on the diagnostic performance of serological assays to detect Aspergillus-specific antibodies in chronic pulmonary aspergillosis (2021) (7)
- Absence of Azole Antifungal Resistance in Aspergillus fumigatus Isolated from Root Vegetables Harvested from UK Arable and Horticultural Soils (2020) (6)
- AmBisome: adds to the body of knowledge and familiarity of use. (2006) (6)
- Detection of Pneumocystis jirovecii by quantitative real-time PCR in oral rinses from Pneumocystis pneumonia asymptomatic human immunodeficiency virus patients. (2019) (6)
- Interlaboratory Analysis of Isavuconazole Plasma Concentration Assays Among European Laboratories (2019) (6)
- Antibody to Aspergillus fumigatus antigens in normal sera: influence on positive-negative discrimination in ELISA. (1984) (6)
- GM-CSF-modulated phagocytosis of Trichosporon beigelii by human neutrophils. (1997) (6)
- Comparative in-vivo activity of clotrimazole and a clotrimazole/hydrocortisone combination in the treatment of experimental dermatophytosis in guinea pigs. (1990) (6)
- ESCMID Diagnostic and management guideline for Candida diseases 2012: Developing European guidelines in clinical microbiology and infectious diseases. (2012) (6)
- Does the triad of fungi, bacteria and exposure to moisture have an impact on chronic hyperplastic sinusitis? (2005) (6)
- Antibiotic use in the treatment of non-streptococcal pharyngitis. (1991) (6)
- Clinical manifestations and management of coccidioidomycosis in the compromised patient. (1990) (6)
- Candida albicans isolates from APECED patients show decreased susceptibility to miconazole. (2009) (6)
- Talaromycosis in a renal transplant recipient returning from South China (2020) (6)
- Deciphering Aspergillus fumigatus cyp51A-mediated triazole resistance by pyrosequencing of respiratory specimens (2020) (6)
- Intracellular killing of Candida albicans by human neutrophils is potentiated by exposure to combinations of amphotericin B and 5‐fluorocytosine (1991) (5)
- Effects of terbinafine exposure on the ultrastructure of Trichophyton interdigitale (1993) (5)
- Enzyme-linked immunosorbent assay of antigens from Candida albicans circulating in infected mice and rabbits: The role of mannan (1979) (5)
- European confederation of medical mycology expert consult—An ECMM excellence center initiative (2020) (5)
- Optimising the cut-off of the Bordier Aspergillus IgG ELISA for the diagnosis of chronic pulmonary aspergillosis. (2020) (5)
- Detection of circulating antigen of Aspergillus fumigatus in sera of mice and rabbits by enzyme-linked immunosorbent assay (1979) (5)
- Evaluation of an enzyme-linked immunosorbent assay (ELISA) for the diagnosis of Aspergillus fumigatus intranasal infection of the dog. (1984) (4)
- Molecular Epidemiology of Aspergillus fumigatus in Chronic Pulmonary Aspergillosis Patients (2021) (4)
- 190 – Superficial and Subcutaneous Fungal Pathogens (2017) (4)
- Effect of amorolfine (Ro 14-4767/002) on in vitro phagocytosis and intracellular killing of Candida albicans by human neutrophils. (2009) (4)
- Ultrastructural features of phagocytosis and intracellular killing of Candida albicans by mouse polymorphonuclear phagocyte monolayers (1983) (4)
- Non-opsonic phagocytosis of Trichophyton mentagrophytes arthroconidia by human neutrophils in vitro. (1995) (4)
- Ketoconazole pharmacokinetics during chronic dosing in adults with haematological malignancy (1986) (4)
- A CONSORT analysis of randomised controlled trials for the treatment of invasive aspergillosis (2016) (4)
- Antibacterial Activity of 2-Hydroxyisocaproic Acid (HICA) Against Obligate Anaerobic Bacterial Species Associated With Periodontal Disease (2021) (4)
- Inter-laboratory analysis of Isavuconazole plasma concentration assays among European laboratories. (2019) (4)
- National mycology laboratory diagnostic capacity for invasive fungal diseases in 2017: Evidence of sub-optimal practice (2019) (3)
- Identification of agents of systemic mycoses (1989) (3)
- Invasive aspergillosis. (2000) (3)
- Chronic mould exposure as a risk factor for severe community acquired pneumonia in a patient requiring extra corporeal membrane oxygenation (2015) (3)
- Tinea infections treated with bifonazole gel. (1988) (3)
- Further evaluation of factors affecting a rapid ELISA procedure for detection of IgG antibodies to Candida albicans (1983) (3)
- Auxarthron alboluteum related to non-dermatophytic toenail infection in Kurdistan region, Iraq: A case report (2019) (3)
- Comprar Fungal Infection: Diagnosis And Management | Malcolm Richardson | 9781405170567 | john wiley sons (2012) (3)
- Pathways and Routes of Natural Exposure to Fungal Infection (2015) (3)
- How the host fights against Candida infections. (2009) (3)
- The Pocket Guide to Fungal Infection (2000) (3)
- Comparison of the growth of virulent and attenuated strains of Candida albicans in the kidneys of normal and cortisone-treated mice by Chitin assay (1979) (3)
- Rapid enzyme-linked immunosorbent assay (ELISA) for detection of IgG antibodies to Candida albicans (2004) (3)
- Positive Aspergillus PCR as a marker of azole resistance or sub‐therapeutic antifungal therapy in patients with chronic pulmonary aspergillosis (2020) (2)
- Pulmonary mycotic infections (2013) (2)
- Candidaemia in a tertiary hospital in Nigeria (2014) (2)
- Stimulation of human neutrophil phagocytosis of Candida albicans by a beta-glucan synthase inhibitor, cilofungin. (1991) (2)
- Clinical manifestations and management of superficial fungal infection in the compromised patient. (1990) (2)
- Antigen selection for optimal serological diagnosis of Aspergillus fumigatus infection of the nasal chambers of the dog (1984) (2)
- Microbial contamination of heater cooler units used in extracorporeal membrane oxygenation is not aerosolized into the environment: A single-center experience (2019) (2)
- Successful treatment of an invasive fungal infection caused by Talaromyces sp. with voriconazole (2015) (2)
- A Case of Primary Invasive Aspergillus Colitis Masquerading as Clostridium difficile Infection. (2016) (1)
- Morphological transition in Pityrosporum ovale. (1996) (1)
- Preface for Advances Against Aspergillosis (2012) (1)
- 1st International Forum on Zygomycosis, 30 May to 1 June 2008 (2009) (1)
- Candida auris is highly virulent and resistant, and capable of forming biofilms (2016) (1)
- Impact of self-reported environmental mould exposure on COPD outcomes. (2021) (1)
- Sero-diagnosis of invasive aspergillosis: Attempts to determine antigen and antibody relevance to infection (1980) (1)
- Fungal infections: guidelines for reporting. PHLS Mycology Committee. (1996) (1)
- An introduction to current standards of CARE in invasive fungal disease. (2019) (1)
- Diagnosis of chronic pulmonary aspergillosis (CPA) complicating pulmonary tuberculosis by chest X-ray (2018) (1)
- Diagnosis of Candida infection in tissue by immunohistochemistry (2006) (1)
- In vitro phagocytosis ofCandida albicans by human polymorphonuclear phagocyte monolayers pretreated with anti-pseudomonal antibiotics (1983) (1)
- Comparison of two genotyping methods reveals clusters of resistant Aspergillus fumigatus from chronic pulmonary aspergillosis patients in the UK (2018) (1)
- Assessment of and future perspectives on standards of CARE in invasive fungal disease. (2019) (1)
- Aspergillus in Indoor Environments (2021) (1)
- Chapter 179 – Superficial and subcutaneous fungal pathogens (2010) (1)
- Special Issue “Fungal Burden in Different Countries” (2018) (1)
- Letter: Diagnosis of invasive aspergillosis. (1976) (0)
- Is invasive aspergillosis community acquired or nosocomial: an ongoing debate (2008) (0)
- A Review of Onychomycosis Due to Aspergillus Species (2017) (0)
- A Rapid Double Antibody Biotin-Streptavidin Elisa for Aspergillus Fumigatus Glycoprotein Antigen (1988) (0)
- Littoral Cell Angioma: Unique, Multifocal Splenic Tumors.: (2005) (0)
- Selected reading: recently published texts and monographs (2008) (0)
- Peroxidase Anti-Peroxidase Staining for the Specific Identification of Fungal Antigens in Tissue Sections (1988) (0)
- A Cross-Sectional Survey to Measure the Prevalence of Chronic Pulmonary Aspergillosis (CPA) Complicating Pulmonary Tuberculosis in Northern Uganda (2017) (0)
- Pyrosequencing of Aspergillus fumigatus cyp51A reveals triazole resistance when susceptibility testing cannot (2018) (0)
- Microbial contamination of heater cooler units used in ECMO is not aerosolised into the environment: a single centre experience. (2019) (0)
- Essential in vitro diagnostics for advanced HIV and serious fungal diseases: international experts’ consensus recommendations (2019) (0)
- ESCMID dagger and ECMM double dagger joint clinical guidelines for the diagnosis and management of mucormycosis 2013 (2014) (0)
- 1 / Validation of diagnostic criteria for chronic pulmonary aspergillosis (CPA) (2018) (0)
- Improving awareness, diagnosis and management of invasive fungal infections in Ghana: establishment of the Ghana Medical Mycology Society (2022) (0)
- Definition of Chronic Pulmonary Aspergillosis in Resource-Constrained Settings (2019) (0)
- Lipid preparations of amphotericin for the treatment of fungal infections (1999) (0)
- 8 / Neglected diseases in Nigerians, diagnostics challenges: Invasive Fungal Infections (2018) (0)
- Aspergillosis inimmunocompromised paediatric patients: associations withbuilding hygiene, design, andindoor air (2011) (0)
- Mycobacterial contamination of heater cooler units used in ECMO is not aerosolised into the environment: a single center experience (2019) (0)
- THE POTENTIAL APPLICATION OF MICROARRAYS FOR THE DIAGNOSIS AND MANAGEMENT OF SYSTEMIC FUNGAL INFECTIONS (2002) (0)
- Candidosis of the Genital Tract in Non-pregnant Women (1985) (0)
- Fungal naildisease: aguide togood practice(report ofaWorking GroupoftheBritish Society forMedical Mycology) (1995) (0)
- Current Topics in Medical Mycology, volume 4: Edited by M. Borgers, R. Hay and M. G. Rinaldi. ISBN 3-540-97504-7. Springer-Verlag, New York. Pp. 274.DM 228.00. (1993) (0)
- The mycobiome of dust from the homes of patients with chronic pulmonary aspergillosis reflects the species identified in sputum samples (2017) (0)
- Spores, fragments and antigens: impact on allergic asthma (2017) (0)
- Detection of Aspergillus antibodies by a new indirect haemagglutination assay (2014) (0)
- P1274 Decreased sensitivity of Candida albicans for azole antifungals - a complication of long-term prophylaxis in APECED patients (2007) (0)
- Clinical manifestations of blastomycosis in the compromised patient. (1990) (0)
- Aspergillus antigenaemia in the diagnosis of invasive aspergillosis (1987) (0)
- Serodiagnosis in the management of aspergillosis. (2014) (0)
- AmBisome today: expanding the perspectives on liposomal amphotericin B. (2006) (0)
- Inhibitory Effect of Terbinafine (Lamisil) on the Invasion of Nails in vitro by Trichophyton mentagrophytes (1994) (0)
- Zygomycosis comes of age. Proceedings of the 1st International Forum on Zygomycosis. May 30-June 1, 2008. Cape Sounion, Greece. (2009) (0)
- Candida Antigen and Arabinitol Levels in the Sera of Patients With Proven or Probable Invasive Candidosis (1988) (0)
- Epidemiologic StudybyDNA Typingofa Candidaalbicans Outbreak inHeroin Addicts (1991) (0)
- Influence ofFoodonthePharmacokinetics ofKetoconazole (1984) (0)
- Comparative performance of galactomannan and Aspergillus PCR in sputum from patients with ABPA and CPA (2016) (0)
- P1273 Activity of posaconazole against clinical isolates of Candida albicans with decreased sensitivity tofiuconazole from autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients (2007) (0)
- MEDICAL WIRE AND EQUIPMENT COMPANY MICRORING YT. REPLY (1991) (0)
- Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation (2018) (0)
- Preface for Advances Against Aspergillosis (2012) (0)
This paper list is powered by the following services:
Other Resources About Malcolm Richardson
What Schools Are Affiliated With Malcolm Richardson?
Malcolm Richardson is affiliated with the following schools:
